학술논문
Full interchangeability in regard to immunogenicity between the infliximab reference biologic and biosimilars CT-P13 and SB2 in inflammatory bowel disease
Document Type
Article
Author
Source
In: Inflammatory Bowel Diseases . (Inflammatory Bowel Diseases, 16 February 2018, 24(3):601-606)
Subject
Language
English
ISSN
15364844
10780998
10780998